Dr. Babul Ram Kulkarni, MD

Dr. Kulkarni practices at Mercy at Southwest Medical Center - HOPD in Saint Louis, Missouri.

Dr. Kulkarni's NPI, 1225200769, was assigned on March 25, 2008. Dr. Kulkarni holds Missouri license 2012011150.

Dr. Kulkarni's primary practice is Mercy at Southwest Medical Center - HOPD, at 7345 Watson Rd, Saint Louis, MO 63119.

Dr. Kulkarni's primary practice is Mercy at Southwest Medical Center - HOPD in Saint Louis, Missouri. Dr. Kulkarni is also affiliated with Mercy Hospital St. Louis. The medical group on file is Mercy Clinic East Communities. Dmand AI also links Dr. Kulkarni to 1 more hospital, 4 group practices and clinics and 3 medical groups, each named with a free account. Dr. Kulkarni's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kulkarni practices, 7 sites in all. Vendor and product names are available with a free account.

Family medicine is Dr. Kulkarni's primary specialty in the NPI Registry, under taxonomy code 207Q00000X. Dmand AI has Dr. Kulkarni's licenses on file in 2 states: Missouri and Minnesota.

CMS data shows 667 Medicare services from Dr. Kulkarni across 9 procedure codes in 2024, for 203 Medicare patients. Medicare paid $52,503 for them. Every service was in an office.

CMS counts 203 Medicare patients who saw Dr. Kulkarni in 2024. The largest group is 65 to 74, with 91 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 8% are also on Medicaid. Their average risk score is 1.22, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Kulkarni's median patient age at 67, with 40% women.

In 2024, Dr. Kulkarni wrote 14,159 Medicare Part D claims for 933 patients. 89% of them were for generic drugs. CMS names the drug for 13,456 of them, across 180 drugs with 11 or more claims each, at $862,357 in total drug cost. In 2023, CMS named 11,658 claims across 173 drugs.

Dr. Kulkarni accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Kulkarni as offering telehealth.

CMS Open Payments shows 455 general payments to Dr. Kulkarni from 47 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Novo Nordisk Inc paid the most, $1,019.